spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  back pain 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 17 Jul 2025
Saluda Medical Announces Full U.S. Launch of EVA(TM) Sensing Technology for Use with the Evoke(R) SmartLoop(TM) System
Devices Neurology Product Launch
 HSMN NewsFeed - 3 Jun 2025
Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 12 Nov 2024
Nevro's HFX iQ(TM) Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Devices Regulatory
 HSMN NewsFeed - 23 Sep 2024
UCB Announces U.S. FDA Approvals for BIMZELX(R) (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jun 2024
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 11 Mar 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA(R) (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Dec 2023
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
Devices FDA
 HSMN NewsFeed - 3 Oct 2023
Amber Implants Announces Start of Clinical Trial with VCFix(R) Spinal System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2023
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 10 Jul 2023
PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovation
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 2 Dec 2022
PainTEQ Expands Leadership Team with New Senior VP of Reimbursement and Market Access
Devices Personnel
 HSMN NewsFeed - 11 Nov 2022
New Company UmiTEQ Aims to Revolutionize Ultra Minimally Invasive Procedures
Devices
 HSMN NewsFeed - 20 Oct 2022
DePuy Synthes Receives FDA Clearance for TELIGEN(TM) System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 4 Oct 2022
Saluda Medical Appoints Laureen DeBuono to Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 10 Jun 2022
Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand(TM) Lateral Cage as an addition to its eZspand(TM) Interbody System.
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 28 Mar 2022
Spine BioPharma Completes Series B Financing
Biopharmaceuticals Orthopaedic Venture Capital
 HSMN NewsFeed - 15 Mar 2022
3Spine, Inc. Raises $33M in Private Series C Round
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 15 Mar 2022
PainTEQ Appoints Two New Vice Presidents
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 22 Feb 2022
Vertos Medical Announces Results Showing Meaningful Mobility Improvement Following mild(R) Procedure
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 11 Feb 2022
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Devices Neurosurgery
 HSMN NewsFeed - 19 Jan 2022
Amber Implants Closes US$10 M Series A Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 Nov 2021
Michael Enxing Appointed President of PainTEQ
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 15 Oct 2021
SpinaFX Medical announces John Soloninka as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 5 Oct 2021
Amber Implants VCFix(R) spinal system receives US FDA Breakthrough designation
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 1 Oct 2021
SpinaFX Medical announces Jeff Cambra as CEO
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 22 Sep 2021
Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jun 2021
ZygoFix Receives CE Clearance for its zLOCK Spinal Fusion System
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 19 May 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Devices FDA
 HSMN NewsFeed - 24 Feb 2021
Nexus Spine Announces Availability of Novel Implants for Spine Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 6 Nov 2020
BioElectronics' ActiPatch(R) Therapy To Be Marketed By DonJoy(R) Advantage
Devices Orthopaedic Distribution
 HSMN NewsFeed - 3 Nov 2020
FDA Approves Updated Label for Endari(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2020
Titan Pharmaceuticals Provides a Strategic & Corporate Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 17 Jul 2020
Lilly's Mirikizumab Superior to Cosentyx(R) (secukinumab) in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Jun 2020
Lilly's Taltz(R) (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Nov 2019
ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of Taltz(R) (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 17 Sep 2019
Kaia Health Announces $8 Million in Funding Led by Optum Ventures
Devices Venture Capital
 HSMN NewsFeed - 26 Aug 2019
Lilly Receives U.S. FDA Approval for Taltz(R) (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2019
Amgen To Acquire Otezla(R) For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jul 2019
Alfa Plus by Solio Receives FDA Clearance: Unique Device Delivers Pain Relief Without Pharmaceuticals
Devices FDA Product Launch
 HSMN NewsFeed - 17 Jul 2019
FDA Clears Erchonia's FX 635 for Relief of Chronic Musculoskeletal Pain
Devices FDA
 HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 May 2019
BioMarin Announces that Phase 3 Cohort of Valoctocogene Roxaparvovec, Gene Therapy Study in Severe Hemophilia A Met Pre-Specified Criteria for Regulatory Submissions in the U.S. and Europe
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2019
Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patients
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2019
U.S. FDA Approves DARZALEX(R) (daratumumab) Split-Dosing Regimen
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Dec 2018
Positive Payor Policy Covering coflex(R) by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 27 Nov 2018
Positive Payor Policy Covering coflex(R) by AmeriHealth Caritas for the Surgical Treatment of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Oct 2018
SpineEX(R) Announces FDA Clearance of Sagittae(R) Lateral Lumbar Interbody Fusion Devices
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 18 Sep 2018
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 13 Sep 2018
FDA Approves CroFab(R) Product Improvements
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Aug 2018
SI-BONE, Inc. Announces France's National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System(R) for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Aug 2018
US Food and Drug Administration Approves ARAKODA(TM) (tafenoquine) tablets for oral use; First preventative antimalarial approved in almost two decades
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 2 Jul 2018
Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2018
Lilly Announces Positive Top-Line Results for Second Phase 3 Study of Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) for TNF Inhibitor-Experienced Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2018
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 20 Jun 2018
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Devices Interventional Radiology Orthopaedic FDA
 HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2018
UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 3 May 2018
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 2 May 2018
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Feb 2018
Lilly Announces Positive Top-Line Phase 3 Results for Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2018
Paradigm Spine Announces Landmark Publication Of coflex(R) Vs. Decompression Alone In The Journal Of Neurosurgery Spine
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jan 2018
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2018
SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Dec 2017
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 20 Nov 2017
Paradigm Spine, LLC Announces - Highmark, Inc. Is 1st Private Payor To Issue Exclusive Positive Coverage Policy For coflex(R) Interlaminar Stabilization(R) Treatment Of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2017
Zimmer Biomet Announces U.S. Launch of Vitality(R)+ and Vital(TM) Spinal Fixation Systems
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 9 Oct 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 26 Sep 2017
DiscGenics Raises $14 Million in Series B Financing
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Sep 2017
Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Jul 2017
Stryker's MultiGen(R) 2 Radiofrequency Generator Receives FDA 510(k) Clearance
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 19 Jun 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2017
Next Generation Lumbar Fusion Devices by Meditech Spine Aims to Improve Surgical Outcomes, Receives FDA Clearance
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 13 Jun 2017
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System(R)
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 12 Jun 2017
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2017
Saluda Medical Secures AU$53 Million in Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 22 May 2017
Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 May 2017
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Mar 2017
U.S. FDA Approves Serenity Pharmaceutical’s Noctiva(TM) (desmopressin acetate) – the First Drug Approved for the Treatment of Nocturia
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory
 HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Nov 2016
Sorrento Therapeutics Closes Acquisition of Scilex
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine
 HSMN NewsFeed - 14 Oct 2016
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2016
Blue Cross Blue Shield of Nebraska Adopts Positive Coverage for Minimally Invasive Sacroiliac Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 6 Sep 2016
Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10(TM) Therapy over Traditional Spinal Cord Stimulation for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Aug 2016
Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2016
Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT(R) for the Relief of Chronic Low Back Pain
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 14 Jul 2016
Bayer Announces the Launch of Aleve(R) Direct Therapy(TM) TENS Device to Help People who Suffer from Lower Back Pain
Devices Product Launch
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 15 Jun 2016
Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System(R) for SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 19 May 2016
Boston Scientific Receives U.S. FDA Approval for Precision Montage(TM) MRI Spinal Cord Stimulator System
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 3 May 2016
Spinal Simplicity Lands Investor In Nueterra Capital, Advances Opportunity For FDA-Cleared Minuteman Fusion Device
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 29 Apr 2016
Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 24 Mar 2016
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2016
Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 4 Mar 2016
Stryker Receives FDA Clearance for Tritanium(R) PL Posterior Lumbar Cage
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2016
SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2016
Medovex Receives Reimbursement for Its DenerveX Facet Joint Syndrome Treatment in Germany
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo(R) European Marketing Authorization Application
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2015
SI-BONE, Inc.(R) Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 14 Oct 2015
Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 21 Sep 2015
TranS1 Announces New Vice President of Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 Aug 2015
Flowonix Medical Inc. Announces FDA Approval of New Product
Devices Drug Delivery FDA
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Apr 2015
Teva Announces FDA Approval of ProAir(R) RespiClick
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Mar 2015
Zyga Technology Announces Launch and First Commercial Use of Updated SImmetry(R) Sacroiliac Joint Fusion System
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 9 Mar 2015
SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 20 Feb 2015
REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Feb 2015
Simplify Medical Announces CE Mark for New MRI Compatible Cervical Artificial Disc
Devices Orthopaedic Radiology Regulatory
 HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Nov 2014
Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2014
European Commission Grants Orphan Drug Designation to Soliris(R) (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jul 2014
Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment
Devices Oncology
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jul 2014
Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX(R)) Once-Weekly Prophylaxis For Hemophilia B
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jul 2014
Paradigm Spine, LLC Announces the Release of Two Independent Prospective Clinical Studies that Substantiate coflex(R) Interlaminar Stabilization After Decompression for the Treatment of Spinal Stenosis
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2014
GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2014
FDA Approves Conversion of Soliris(R) (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2014
SI-BONE, Inc. Closes $33 Million Growth Capital Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Apr 2014
World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval
Devices Neurology FDA
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2014
St. Jude Medical Announces European Launch of Prodigy Spinal Cord Stimulation System with Burst Technology
Devices Neurology Product Launch
 HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2014
Dolphin Neurostim Receives CE Approval for European Distribution
Devices Neurology Regulatory
 HSMN NewsFeed - 11 Mar 2014
BioElectronics Appoints Deepak Kotak, MD, Esq as Executive Vice President
Devices Personnel
 HSMN NewsFeed - 10 Mar 2014
Mainstay Medical Begins Clinical Trial of ReActiv8(R) for People with Chronic Low Back Pain
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Devices FDA
 HSMN NewsFeed - 6 Jan 2014
SI-BONE, Inc. Announces 10,000 Procedure Milestone
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology
 HSMN NewsFeed - 3 Dec 2013
St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Sep 2013
Cimzia(R) (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2013
Ortho Kinematics Receives FDA 510(k) Clearance to Expand into Cervical Spine
Devices Orthopaedic FDA
 HSMN NewsFeed - 1 Aug 2013
Intrinsic Therapeutics Announces the Enrollment of the 400th Patient in Landmark Barricaid(R) Randomized Trial
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 19 Jul 2013
Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
Devices Neurology
 HSMN NewsFeed - 18 Jul 2013
Spinal Restoration, Inc. Announces Disappointing Phase III Study Results for the Biostat(R) System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2013
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
Devices Orthopardic Neurosurgery FDA
 HSMN NewsFeed - 16 Jul 2013
Alexion’s Soliris(R) (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 10 Jul 2013
Zimmer Announces Distribution Of APEX Spine System
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 28 Jun 2013
Dendreon Receives Positive Opinion for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 31 May 2013
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Apr 2013
Flowonix Medical Inc. Announces US Market Launch of the Prometra(R) Programmable Intrathecal Drug Infusion Pump
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 22 Mar 2013
Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 Implantations
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 19 Mar 2013
BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
Devices Wound Care Distribution
 HSMN NewsFeed - 18 Mar 2013
SinuSys Corp. Expands Executive Team
Devices Personnel
 HSMN NewsFeed - 1 Mar 2013
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Devices Orthopaedic
 HSMN NewsFeed - 19 Feb 2013
Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 8 Jan 2013
Neurodevice Firm SPR(TM) Therapeutics Raises $5M Series A
Devices Neurology Venture Capital
 HSMN NewsFeed - 12 Nov 2012
Abbott Announces First Long-term Patient-reported Health Outcomes Data for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2012
Ortho Kinematics Expands Leadership Team
Devices Orthopaedic
 HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 30 Oct 2012
European Commission approves Cialis(R) (tadalafil) tablets for the treatment of the signs and symptoms of benign prostatic hyperplasia
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 24 Oct 2012
Paradigm Spine LLC & OM HealthCare Logistics Sign Multi-Year Logistics Agreement
Devices Neurosurgery Orthopaedic Distribution
 HSMN NewsFeed - 22 Oct 2012
Spinal Restoration, Inc. Closes $5 Million Equity and Debt Financing Round
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2012
FzioMed Announces 300,000 Units of Oxiplex Sold
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 20 Sep 2012
Acton Pharmaceuticals Announces U.S. Food and Drug Administration Approval for AEROSPAN(R) (Flunisolide HFA, 80 mcg) Inhalation Aerosol for Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Aug 2012
Alphatec Spine Launches New MIS Device, the BridgePoint(TM) Spinous Process Fixation System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Aug 2012
Genentech Study Showed That Adding Avastin to Radiation and Chemotherapy Significantly Extended the Time People with an Aggressive Form of Brain Cancer Lived without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jul 2012
FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Jul 2012
Neurotech(R) Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain
Devices Orthopaedic
 HSMN NewsFeed - 18 Jul 2012
Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 12 Jul 2012
Integrity Life Sciences Receives CE Mark and ISO Certifications for the Integrity Spinal Care System Medical Device
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
Devices
 HSMN NewsFeed - 2 Jul 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jun 2012
Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2012
Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 31 May 2012
New Data Showed LIVALO(R) (pitavastatin) Met Primary Endpoint of LDL-C Reduction When Compared with Pravastatin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2012
Spinal Kinetics Wins Another Round in Synthes' Patent Litigation
Devices Neurosurgery Orthopaedic Litigation
 HSMN NewsFeed - 2 May 2012
New Case Study Reviews Fracture Reduction and Stabilization of a L1 Burst Fracture Using Combined Anterior and Posterior Approach
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 May 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO(TM) (taliglucerase alfa) For The Treatment Of Gaucher Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2012
RF-TVA Therapy Offers Hope for Patients Suffering from Osteoporosis-Related Spine Fractures
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 9 Apr 2012
DA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Biopharmaceuticals Radiology Neurology FDA
 HSMN NewsFeed - 23 Mar 2012
Ascendx Spine(TM) Appoints Eric W. Gilbert as Vice President of Sales & Marketing for its U.S. Operations
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 15 Mar 2012
Simpirica Spine Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex(TM) Spinal Stabilization System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 5 Mar 2012
BioElectronics Announces New Distribution Agreements for China, the Middle East and Other Global Opportunities
Devices Distribution
 HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2011
Mazor Robotics Enters US Spine Ambulatory Surgery Center Market
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 29 Nov 2011
Soliris(R) (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Nov 2011
Ascendx Spine(TM) Appoints Pilar Debelius-Kinsey as Sales and Marketing Manager, Europe
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 Nov 2011
Dendreon Announces the Centers for Medicare and Medicaid Services (CMS) Will Now Cover Infusion Costs Associated with the Administration of PROVENGE
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 8 Nov 2011
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2011
Abbott Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2011
FDA Approves Addition of Sustained Overall Survival Advantage (5-year follow-up) to Label for VELCADE(R) in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Oct 2011
Spinal USA Gets FDA Approval for Two New Spinal Treatment Products
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 25 Oct 2011
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2011
Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT(R) MRI
Devices Radiology Neurology
 HSMN NewsFeed - 19 Sep 2011
FDA Approves New Indications for Prolia(R) (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2011
Zimmer Receives Pediatric Clearance for Universal Clamp Spinal Fixation System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2011
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Aug 2011
Relievant Medsystems Receives FDA Approval to Begin Pivotal Study to Evaluate the Intracept System for Minimally Invasive Treatment of Chronic Low Back Pain
Devices FDA
 HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA
 HSMN NewsFeed - 5 Jul 2011
Study Suggests Lower Cement Leakage Rate with DFINE Radiofrequency Targeted Vertebral Augmentation(TM) (RF-TVA) in the Treatment of Vertebral Compression Fractures
Devices Neurosurgery Orthopaedic Radiology
 HSMN NewsFeed - 23 May 2011
St. Jude Medical Announces Australian Market Launch for First-of-Its-Kind Neurostimulation Lead Delivery System for Chronic Pain
Devices
 HSMN NewsFeed - 16 May 2011
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 29 Apr 2011
Zimmer Introduces New Generation of the Wallis(R) Dynamic Stabilization System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Apr 2011
Medyssey Spine Receives 510(k) Clearance for Its LP Cage(TM) Posterior Lumbar Interbody Fusion System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Apr 2011
Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Apr 2011
Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Apr 2011
Alexion Submits Applications for Soliris(R) (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2011
iTech Medical Appoints Warren G. Baker as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 24 Mar 2011
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 21 Mar 2011
Kyphon(R) Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 17 Mar 2011
Nevro Appoints Michael DeMane President and Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 8 Mar 2011
Ortho Kinematics Appoints New VP of Sales and Director of Clinical Operations
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 1 Mar 2011
Forest Announces FDA Approval of Daliresp(TM) (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Dec 2010
Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2010
BioElectronics Introduces Its New Disposable Device to the US Market
Devices
 HSMN NewsFeed - 8 Dec 2010
Ortho Kinematics Raises $2 Million in New Funding
Devices Venture Capital Orthopaedic Neurosurgery
 HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology
 HSMN NewsFeed - 2 Dec 2010
St. Jude Medical Announces New Approvals of Five-Column Neurostimulation Lead to Manage Chronic Pain at 14th Annual North American Neuromodulation Society Meeting
Devices Neurology Regulatory
 HSMN NewsFeed - 17 Nov 2010
Titan Spine Receives Regulatory Clearance to Launch Endoskeleton(R) TO PLIF and Oblique Interbody Fusion Devices
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Nov 2010
Titan Spine Appoints Vice President of Marketing
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2010
Phase III Novartis Data Show Potential Benefit of Afinitor(R) Plus Sandostatin(R) LAR Depot in Patients with Advanced Carcinoid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Oct 2010
Integra LifeSciences Receives FDA Clearance for Multiple Fixation Options for Vu aPOD(TM) Prime ALIF Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 5 Oct 2010
SpinalMotion Completes Enrollment in International Clinical Study for Kineflex(R) Lateral Lumbar Disc
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Oct 2010
Titan Spine Launches Alternative Bioactive Cervical Device
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2010
Phase III Data Showing Improved Survival With Jevtana(R) (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Sep 2010
Wenzel Spine Announces FDA 510K Clearance
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Sep 2010
FDA Approves New Dosing for FASLODEX(R) (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Sep 2010
Accentus Medical Signs Global Licence Agreement with Zimmer
Devices Orthopaedic Licensing
 HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Jul 2010
Abbott's SIMCOR(R) (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 23 Jul 2010
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA(R) Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2010
Boston Scientific Announces FDA Approval and Launch of Lead Splitters for the Precision Plus Spinal Cord Stimulator System
Devices FDA
 HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2010
Anulex Technologies, Inc. to Raise a Minimum of $20 Million in Series E Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 1 Jun 2010
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 16 Mar 2010
Spinal Restoration Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System
Devices Orthopaedic
 HSMN NewsFeed - 12 Mar 2010
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2010
Stryker Interventional Spine Launches VertaPlex(R) HV
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 25 Feb 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Feb 2010
Anulex Technologies, Inc. Announces the Launch of the Xclose Plus Tissue Repair System and Achieves 7,300 Patients Treated Milestone
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 22 Jan 2010
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2010
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 18 Dec 2009
Medtronic Introduces the SOVEREIGN Spinal System for Lumbar Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Dec 2009
6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Dec 2009
VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
Devices
 HSMN NewsFeed - 17 Nov 2009
Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Nov 2009
Ortho Kinematics Raises $3.5 Million and Relocates to Austin, TX
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 9 Nov 2009
Titan Spine Appoints Accomplished Spine Surgeon Paul Slosar, MD as Medical Director
Devices Personnel Neurosurgery Orthopaedic
 HSMN NewsFeed - 6 Nov 2009
Facet Solutions Acquires Archus Orthopedics
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 Oct 2009
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2009
Surgeon Performs Outpatient Spine Surgeries with US Spine's Lock-Tight Device
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Aug 2009
Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Biopharmaceuticals Onology
 HSMN NewsFeed - 18 Aug 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Aug 2009
Titan Spine's Interbody Device Participates in the Fusion Process
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 5 Aug 2009
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN(R) (ezetimibe/simvastatin) and ZETIA(R) (ezetimibe)
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 3 Aug 2009
FDA Approves Avastin for the Most Common Type of Kidney Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jun 2009
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2009
Dynatronics Begins Shipping New V-Force Vibration Therapy Units
Devices
 HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Jun 2009
HydroCision Introduces the "Walk in/Walk out" Option for Treatment of Herniated Discs
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 9 Jun 2009
Spinal Restoration Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 3 Jun 2009
CE Mark Extended for Disc Dynamics' DASCOR Disc Arthroplasty System
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 1 Jun 2009
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2009
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2009
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 May 2009
UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 May 2009
Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Apr 2009
ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
Devices Orthopaedic Regenerative Medicine FDA
 HSMN NewsFeed - 27 Apr 2009
First Ever Prospective Fracture Study in Prostate Cancer Patients on ADT Reveals These Men Are at High Risk for Skeletal Fractures
Biopharmaceuticals Oncology Urology
 HSMN NewsFeed - 22 Apr 2009
Magellan Spine Technologies Receives CE Mark for the DART(TM) Spinal Disc Annular Repair Technology
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 16 Apr 2009
BIOLASE Announces FDA 510(K) Clearance of Its ezlase(TM) Diode Laser for Pain Therapy & Relief
Devices FDA
 HSMN NewsFeed - 1 Apr 2009
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 18 Mar 2009
FIRMAGON(R) (Degarelix) is Launched in Europe for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Biopharmaceuticals
 HSMN NewsFeed - 9 Mar 2009
IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Genzyme's Synvisc-One for Osteoarthritis of the Knee
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2009
Largest Study on Balloon Kyphoplasty Demonstrates Superior Benefits Compared to Non-Surgical Care in Treating Vertebral Compression Fractures
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 9 Jan 2009
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2008
Newly Published Data from Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality of Life and Functional Capacity
Devices Neurosurgery
 HSMN NewsFeed - 30 Oct 2008
Pioneer(R) Surgical Technology's NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2008
New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
Biopharmaceuticals
 HSMN NewsFeed - 14 Oct 2008
Interventional Spine, Inc. Acquires Intellectual Property for New PERCUTANEOUS Spinal Disc Replacement System
Devices Neurosurgery Orthopaedic Acquisitions
 HSMN NewsFeed - 8 Oct 2008
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 20 Sep 2008
Acorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Sep 2008
Scient'x Launches Tribeca(TM) TLIF Cage System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 17 Sep 2008
Medtronic Launches Discyphor Direct(TM) Catheter System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 15 Sep 2008
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2008
FDA Grants Approval to Talecris Biotherapeutics for Gamunex(R) as a Treatment for Neurological Disorder CIDP in the United States
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Sep 2008
EpiCept Amends DURECT Bupivacaine Patch Licensing Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Sep 2008
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Aug 2008
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2008
Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Jul 2008
FDA Approves Expanded 510k Classification for Titan Spine's ENDOSKELETON(R) TA Anterior Interbody Fusion Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 25 Jul 2008
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2008
minSURG(TM) Corporation Launches International Division
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 14 Jul 2008
Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2008
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 27 Jun 2008
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals
 HSMN NewsFeed - 25 Jun 2008
TranS1 Inc. Announces the First Patients Treated With Its Percutaneous Nucleus Replacement, PNR, in Europe
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 25 Jun 2008
Applied Spine Technologies reports Stabilimax NZ(R) clinical trial milestone: enrollment surpasses 100 patients; 5 new sites added, boosting total to 21
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 2 Jun 2008
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 May 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 May 2008
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 May 2008
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
Biopharmaceuticals
 HSMN NewsFeed - 13 May 2008
Spinal Restoration, Inc. Receives FDA IDE Approval
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 12 May 2008
Studies Presented at Spine Arthroplasty Society Annual Meeting Find Plasma Disc Decompression Effective for Contained Disc Herniation
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
KV Begins Shipping Evamist(TM) to Wholesalers
Biopharmaceuticals
 HSMN NewsFeed - 3 Apr 2008
ArthroCare Unveils New Direction in Treatment of Metastatic Lesions
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 Apr 2008
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2008
Medtronic Commends World Health Organization for Spinal Fracture Risk Tool
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 20 Mar 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
 HSMN NewsFeed - 18 Mar 2008
Titan Spine's ENDOSKELETON(R) TA Passes Test In Competitive Lower Back Pain Market
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 18 Mar 2008
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Biopharmaceuticals Litigation
 HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2008
NeuroMetrix and Cyberkinetics Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 19 Feb 2008
Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 15 Feb 2008
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 Feb 2008
Positive Results from Phase III Trial of Gamunex(R) in Patients with CIDP
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2008
FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2008
''Motion-preservation'' Spine Company Applied Spine Technologies Appoints Chief Medical Officer: Michael J. Giordano, MD, MBA
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2008
Sepracor Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Jan 2008
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2008
Denosumab Osteoporosis Study Met Primary and All Secondary Bone Mineral Density Endpoints in a Head-to-Head Comparison with Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2008
Back pain treatment milestone: Bon Secours DePaul Medical Center orthopedic surgeon is first in Virginia to implant 'motion preserving' spinal device to treat Lumbar Spinal Stenosis
Devices Orthopaedic
 HSMN NewsFeed - 17 Jan 2008
Spinal Elements(TM) Announces Successful Completion of Landmark Spine Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 16 Jan 2008
Groundbreaking Medical Device Helps Woman Win Battle Against Cancer
Devices Oncology
 HSMN NewsFeed - 16 Jan 2008
ALVESCO(R) Gains FDA Approval for the U.S. Market
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2008
FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2007
SpineOvations to Acquire Discogen Technology
Devices Neurosurgery Orthopaedic Acquisitions
 HSMN NewsFeed - 18 Dec 2007
IST Study Demonstrates Benefits of Minimally Invasive Lumbar Fusion Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 14 Dec 2007
Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2007
Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
SpineOvations Names Robert R. Anglea to Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
Javelin Pharmaceuticals Launches Dyloject(R) in UK
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2007
Exactech to Acquire Altiva Corporation
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Dec 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2007
Merck/Schering-Plough Pharmaceuticals Provides Update on ENHANCE Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Nov 2007
Cost-Effective Spinal Discography Device Receives FDA Clearance: Pinyons Medical Technology's PowrSyringe Expands with New Spine Indication
Devices Orthopaedic FDA
 HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology
Return to NewsFeed  

 Additional items found! 336

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 336 additional stories matching:
back pain
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.